Invest now

Akums Drugs and Pharmaceuticals Profit & Loss Annual

BSE: 544222 | NSE: AKUMS | ISIN: INE09XN01023 | Sector: Biotechnology & Drugs
743.70 -0.70 (-0.09%)Updated : 18 Aug 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 4,011.373,793.823,847.813,537.46
Other Net -72.6914.4013.9428.32
Diluted Weighted Average Shares 15.3114.9615.7415.74
Gain( Loss)on Saleof Assets 0.013.72-1.042.06
Depreciation/ Amortization 154.55153.45125.64112.81
Operating Income 347.65324.34330.37117.36
Net Income 255.19338.18-4.0494.85
Income Availableto Com Excl Extra Ord 255.19338.18-4.0494.85
Other Operating Expenses Total 62.8055.8759.2263.33
Net Income Before Taxes 382.10345.25-45.28150.30
Minority Interest -1.21-5.60-4.83-2.96
Net Income After Taxes 256.40343.780.7997.82
Income Availableto Com Incl Extra Ord 255.19338.18-4.0494.85
Costof Revenue Total 2,732.502,629.792,743.022,454.88
Gross Profit 1,626.521,488.371,435.161,199.94
Interest Inc( Exp) Net- Non- Op Total 107.142.80-388.552.56
Unusual Expense( Income) 20.02-16.7025.1769.75
Diluted Net Income 255.19338.18-4.0494.85
DPS- Common Stock Primary Issue 1.00-0.000.00
Provisionfor Income Taxes 125.701.48-46.0752.48
period Type ----
Net Income Before Extra Items 255.19338.18-4.0494.85
Total Revenue 4,359.024,118.164,178.183,654.82
period Length 12.0012.0012.0012.00
Revenue 4,359.024,118.164,178.183,654.82
Selling/ General/ Admin Expenses Total 1,041.50971.42894.75836.70
Diluted Normalized EPS 17.5521.250.838.83
Diluted EPS Excluding Extra Ord Items 16.6722.60-0.266.03
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,241.00+11.00(0.89%)
2,630.25-64.75 (-2.40%)